Among them, peroxisome proliferator-activated receptors gene (PPAR) (11), leptin receptor (LEPR) (12, 13), apolipoprotein C3 (APOC3) (14, 15) and so on have been reported to be associated with NAFLD and CAD (6). This evidence concerns the gene APOC3 and metabolic dysfunction-associated steatotic liver disease.